SS

Sona Saira Ramasastry

Active Director Director DIN 08398547
DIN 08398547 First appointment Apr 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2019
Shareholding value •••• Premium profile

About Sona Saira Ramasastry

Data last updated:

Sona Saira Ramasastry is a Director at Glenmark Pharmaceuticals Limited (since 2019). The company operates in Pharma. Glenmark Pharmaceuticals Limited reported revenue of ₹17,443 Cr (FY 2026).

DIN 08398547
Primary Designation Director
Industry Pharma
First Appointment 01 Apr 2019
Oldest Company Age 48 yrs
Largest company Glenmark Pharmaceuticals Limited · ₹17,443 Cr (FY 2026)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Glenmark Pharmaceuticals Limited L24299MH1977PLC019982
Director01 Apr 20191977₹17,443 Cr (FY 2026)Active

Directorship timeline

Open interactive timeline →
Glenmark Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Sona Saira Ramasastry

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sona Saira Ramasastry

Sona Saira Ramasastry currently holds 1 directorship: Glenmark Pharmaceuticals Limited (Director, since 01 Apr 2019, revenue ₹17,443 Cr (FY 2026)).

Sona Saira Ramasastry was first appointed on 01 Apr 2019 as Director at Glenmark Pharmaceuticals Limited.

The current boards of Sona Saira Ramasastry's companies include Anurag Mantri (Glenmark Pharmaceuticals Limited), Anurag Mantri (Glenmark Pharmaceuticals Limited), Blanche Saldanha Elizabeth (Glenmark Pharmaceuticals Limited), Cherylann Maria Pinto (Glenmark Pharmaceuticals Limited), Dipankar Bhattacharjee (Glenmark Pharmaceuticals Limited), Glenn Mario Saldanha (Glenmark Pharmaceuticals Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available